1. Home
  2. GCTS vs LPCN Comparison

GCTS vs LPCN Comparison

Compare GCTS & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GCT Semiconductor Holding Inc.

GCTS

GCT Semiconductor Holding Inc.

HOLD

Current Price

$1.17

Market Cap

60.5M

Sector

Finance

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$8.97

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCTS
LPCN
Founded
1998
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.5M
61.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GCTS
LPCN
Price
$1.17
$8.97
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.50
$15.00
AVG Volume (30 Days)
9.0M
198.7K
Earning Date
11-12-2025
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,893,000.00
$4,322,693.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1,184.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$2.52
52 Week High
$2.47
$12.37

Technical Indicators

Market Signals
Indicator
GCTS
LPCN
Relative Strength Index (RSI) 50.92 54.96
Support Level $0.96 $8.80
Resistance Level $1.84 $11.11
Average True Range (ATR) 0.14 1.17
MACD 0.02 -0.32
Stochastic Oscillator 23.16 22.88

Price Performance

Historical Comparison
GCTS
LPCN

About GCTS GCT Semiconductor Holding Inc.

GCT Semiconductor Holding Inc is a designer and supplier of 5G and 4G LTE semiconductor solutions. It enabled fast and reliable 4G LTE connectivity to numerous commercial devices such as CPEs, mobile hotspots, routers, M2M applications, and smartphones, etc. The system-on-chip solutions integrate radio frequency, baseband modem, and digital signal processing functions, therefore offering complete 4G and 5G platform solutions with small form factors, low power consumption, high performance, high reliability, and cost-effectiveness.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: